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PKC signaling prevents irradiation-induced apoptosis
of primary human fibroblasts
A Bluwstein1,2, N Kumar3, K Le´ger1,2, J Traenkle4, J van Oostrum5, H Rehrauer6, M Baudis3 and MO Hottiger*,1
Primary cells respond to irradiation by activation of the DNA damage response and cell cycle arrest, which eventually leads to
senescence or apoptosis. It is not clear in detail which signaling pathways or networks regulate the induction of either apoptosis
or senescence. Primary human fibroblasts are able to withstand high doses of irradiation and to prevent irradiation-induced
apoptosis. However, the underlying regulatory basis for this phenotype is not well understood. Here, a kinetic network analysis
based on reverse phase protein arrays (RPPAs) in combination with extensive western blot and cell culture analyses was
employed to decipher the cytoplasmic and nuclear signaling networks and to identify possible antiapoptotic pathways. This
analysis identified activation of known DNA damage response pathways (e.g., phosphorylation of MKK3/6, p38, MK2, Hsp27, p53
and Chk1) as well as of prosurvival (e.g., MEK-ERK, cAMP response element-binding protein (CREB), protein kinase C (PKC)) and
antiapoptotic markers (e.g., Bad, Bcl-2). Interestingly, PKC family members were activated early upon irradiation, suggesting a
regulatory function in the ionizing radiation (IR) response of these cells. Inhibition or downregulation of PKC in primary human
fibroblasts caused IR-dependent downregulation of the identified prosurvival (CREB phosphorylation) and antiapoptotic (Bad
phosphorylation, Bcl-2) markers and thus lead to a proliferation stop and to apoptosis. Taken together, our analysis suggests
that cytoplasmic PKC signaling conditions IR-stressed MRC-5 and IMR-90 cells to prevent irradiation-induced apoptosis. These
findings contribute to the understanding of the cellular and nuclear IR response and may thus eventually improve the efficacy of
radiotherapy and help overcome tumor radioresistance.
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Genotoxic stress such as ionizing radiation (IR) causes DNA
damage and thereby induces diverse cellular responses such
as cell cycle arrest and the activation of the DNA damage
response (DDR) pathways to deal with this threat.1 These
complex DDRs are regulated by the PI3K-like kinases ATM,
ATR and DNA-PK, which regulate downstream effectors that
induce cell cycle checkpoints via phosphorylation of check-
point kinases (Chk1/2), phosphatases (Cdc25) as well as
stabilization of p53 and activation of the p16INK4a-Rb
pathway to delay progression into the S phase or mitosis.2
Following the detection of DNA breaks, ATM initiates a
nuclear signaling cascade, leading to the phosphorylation of
protein substrates such as histone H2A.X, which is thus
modified into gH2A.X and sensitively marks individual DNA
breaks.3 Depending on the cell type, prolonged cell cycle
arrest and extensive DNA damage leads to apoptosis or
senescence,4–6 but the molecular mechanism leading to
either of these outcomes is not understood in detail. Recent
large-scale network analyses have extended our under-
standing not only of genotoxic stress signaling and identified
new phosphorylation but also of acetylation sites and target
proteins mainly in the nucleus.7–11 Reverse phase protein
arrays (RPPA) represent a powerful technology for the
sensitive detection and high-throughput quantification of
protein changes at the single-cell level in a multiplex
setting.12,13 Protein arrays have already been applied to
study changed expression levels or post-translational mod-
ification status of proteins in cellular stress conditions or in
normal and cancerous prostate and ovarian tissue.10,13–15
Depending on the cell type, IR induces different responses
and proteome changes. MRC-5 primary human lung fibro-
blasts were used in this study as a model cell strain, because
these cells tolerate IR doses up to 80Gy and do not induce
apoptosis.16,17 Here, we applied the RPPA technology to
study IR-induced stress pathways in primary cells on a
‘signalosome level’ by analyzing cellular candidate markers.
The RPPAs were probed with 165 different antibodies to
quantify the major components and post-translational mod-
ifications of nuclear and cytoplasmic stress signaling events.
Besides classical components of the DDR, such as protein
level and phosphorylation changes in Chk1, p53, p21 and
cyclin D1, as well as activation of the MEK-ERK, p38-Hsp27
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and LKB-AMPK pathways, the RPPA analysis described here
also identified specific components of the cellular IR response
involved in antiapoptotic and prosurvival signaling. Among
these changes was also the activation of PKC familymembers.
The PKC signaling pathway is known to integrate extracellular
signals, calcium and secondary lipid messengers (diacylgly-
cerol, phosphatidylserine), to regulate diverse cellular
responses, including apoptosis or survival during genotoxic
stress.18–20 We found that experimental inhibition or down-
regulation of PKC led to downregulation of prosurvival (cAMP
response element-binding protein (CREB) phosphorylation)
and antiapoptotic (Bad phosphorylation, Bcl-2) markers upon
IR treatment and thus lead to apoptosis in normal humanMRC-
5 and IMR-90 fibroblasts (normal human fibroblasts (NHFs)).
These results thus implicated significantly changed kinetics of
prosurvival (CREB phosphorylation) and antiapoptotic (Bad
phosphorylation, Bcl-2) key determinants in the ability to
prevent apoptosis upon severe DNA damage. IR-induced
PKC signaling is thus defined as the mechanism that prevents
IR-induced apoptosis.
Results
IR induces a DDR and senescence in MRC-5 fibroblasts.
To induce DNA damage, primary human MRC-5 fibroblasts
were irradiated with doses of 10 and 40Gy. Both doses
induced key components of the classical DDR, including
phosphorylation of ATM at serine 1981 (pS1981), of Chk1 at
serine 345 (pS345), of H2A.X at serine 139 (pS139) and
stabilization of p53 protein levels (Figure 1a). The IR doses
were chosen based on preliminary experiments and reflect
the high capacity to repair IR-induced DNA damage of MRC-
5 cells, which have been shown to efficiently remove DNA
strand breaks (DSBs) up to IR doses of 80Gy16 and to enter
the senescent state upon treatment with various stress
stimuli.21 In agreement with these findings, irradiation of
MRC-5 cells with IR doses between 4 and 10Gy induced a
dose-dependent increase and time-dependent decrease of
H2A.X pS139 that was mediated by ATM and DNA-PK
(Figures 1b and c). The majority of DSBs was repaired
within 8 h post-irradiation as indicated by the reduction of
gH2AX foci and the remaining gH2AX foci continued to be
repaired 24–48 h following IR treatment (Supplementary
Figures S1a and b).
The strong reduction in colony formation of single cells after
10 days and the appearance of b-galactosidase-positive cells
(MRC-5 and IMR-90) by 72 h after irradiation indicated growth
arrest and induction of cell senescence (Supplementary
Figures S1c and d), which was further supported by elevated
p21 gene expression as well as p21 and p16 protein levels in
MRC-5 and IMR-90 primary fibroblasts (Supplementary
Figures S1e–g). Irradiation caused only a slight increase in
the G2/M cell cycle population, but this effect was intensified
upon ATM inhibition, suggesting that the efficient DDR
prevented a more pronounced effect on cell cycle progression
of irradiated MRC-5 cells (Supplementary Figures S2a–d).
Cells did not exhibit elevated apoptosis even at the 8 h time
point after 40Gy irradiation, as indicated by the stable fraction
of Annexin V-positive cells and undetectable expression of
NOXA, PUMA and Bax (relative to a significant increase after
staurosporine or cycloheximide treatment; Supplementary
Figures S3a–d).
These results documented the suitability of 10 and 40Gy IR
to induce non-lethal, but senescence responses in primary
fibroblasts.
IR induces significant proteome changes in MRC-5
fibroblasts. To quantify the kinetic proteome changes upon
IR, MRC-5 fibroblasts were harvested at the 0.5, 2, 4 and 8 h
time points after IR exposure (10 and 40Gy) and RPPA
analysis was performed (Figure 2a and Supplementary
Figure S4). The time points were chosen based on the
observed kinetics of gH2AX activation (Figure 1b) and were
similar to those used in earlier studies.7 The protein arrays
were probed with 165 validated antibodies that specifically
recognize the activation state of crucial proteins of all major
signaling pathways. Only antibodies previously assessed
and certified for commercial RPPA analysis services
(identifying only one single band in a conventional western
blot) were used and the spotted protein samples were diluted
to increase the dynamic range for protein detection.13 All
quantitative RPPA data of three independent biological
experiments (eight technical replicates) were subjected to
stringent statistical analysis (ANOVA: Po0.05 and fold
change cutoff: fold change Z1.5S.D.) (Supplementary
Figures S5–9). Altogether, 90 unique proteome changes
were either significant based on ANOVA and/or passed the
1.5S.D. cutoff (Supplementary Figures S6 and 7 and
Supplementary Table).
Clustering analysis identifies early cytoplasmic signals
and subsequent activation of classical DDR proteins.
The analysis described here identified distinct clusters based
on the temporal up- and downregulation of specific proteins
or protein modifications. In general, treatment of MRC-5
fibroblasts with 40Gy induced more distinct clusters as
compared with 10Gy irradiation and three broad groups were
apparent (Figures 2b and c and Supplementary Figures
S10a and -b). The earliest changes affected many cytoplas-
mic proteins such as MEK1/2 (pS217/222, pS221/226),
ERK1/2 (pT202/185, pY204/187), LKB (pS428) and cyclin
D1 (pT286), which were sharply induced at 0.5 h after
irradiation and relaxed to much lower and constant levels
thereafter (cluster 1; Figure 2c and Supplementary Figure
S10b). Following this first wave of protein changes, a cluster
with a distinct maximum at 2 h after 40Gy IR appeared
(clusters 2 and 5). The protein changes that appeared at later
time points after 40Gy IR comprised changes that were
upregulated throughout the entire IR response or specifically
increased by the higher IR dose (clusters 3 and 4). The
consecutive activation and inactivation of different groups of
proteins indicated a signaling cascade that progresses from
the cytoplasm (early activation of MEK1/2, ERK1/2, LKB) to
the nucleus (delayed activation of classical nuclear DDR
proteins such as Chk1, p53, p21, MAPKAP2, Hsp27).
Validation of RPPA analysis confirms upregulation of
known DDR pathways and identifies pRb downregula-
tion. The detection of many classical DDR proteome
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changes upon both 10 and 40Gy IR validated the RPPA
analysis of IR-treated MRC-5 fibroblasts. Known proteome
changes of the DDR pathway included higher total amounts
of p53 and p21 as well as increased levels of phosphorylated
p38 MAPK (pT180, pY182), Hsp27 (pS78), p53 (pS15) and
Chk1 (pS345) (clusters 1–3 for 10Gy and clusters 2–5 for
40Gy; Figures 2b and c and Supplementary Figures S10a
and -b). In addition, Chk1 phosphorylation upon 10 and
40Gy IR was confirmed by western blot analysis (Figure 1a
and Supplementary Figure S10c). Levels of Chk1 phosphor-
ylation determined by RPPA and western blot analysis
showed similar kinetics (early increase after 30min recovery
from IR followed by a decline over the 8 h time course) and
thus confirmed the validity of the RPPA approach. IR-
induced Chk2 phosphorylation could only be shown by
western blotting because of its poor antibody performance on
the arrays (Supplementary Figure S10f). Even though
ANOVA (Po0.05) and fold cutoff (S.D.¼ 1.5) analysis did
not reveal significantly changed phosphorylation of the
classical DDR marker H2A.X (pS139) in response to 10Gy,
at the 2 h time point, the Student’s t-test showed a
significantly increased H2A.X phosphorylation (Po0.05)
(Supplementary Figures S7 and 8). The kinetics of H2A.X
phosphorylation upon 10 and 40Gy correlated well, but the
higher dose resulted in a stronger fold induction
(Supplementary Figures S8 and 9). In agreement with
previously published studies,22 activation of the cytoplasmic
stress kinase p38 MAPK and its downstream effector, the
small heat-shock protein Hsp27, were both ATM-dependent
as confirmed by western blotting and ATM inhibitor studies
(Supplementary Figure S10d). Other proteome changes that
were also analyzed by western blotting similarly confirmed
the RPPA results, albeit western blotting revealed higher fold
changes. Temporarily increased levels of p53, which is the
main target for ATM in response to IR,2 correlated with
delayed upregulation of p21 (clusters 1 and 2 for 10Gy;
Figure 2b). Surprisingly, the important cell cycle regulator
retinoblastoma protein (pRb) was significantly downregulated
upon 10Gy irradiation (cluster 5; Figure 2b), representing a
proteome change that has not been implicated in the IR
response previously. The RPPA-based pRb quantification
correlated strongly with results obtained by western blotting
(Supplementary Figures S10e and f), supporting in vivo pRb
downregulation upon IR in MRC-5 fibroblasts. In contrast to
total pRb levels, the phosphorylation of pRb at S780 (relative
to total pRb) increased upon 10Gy after 8 h and already
after 2 h following irradiation with 40Gy (Supplementary
Figure S10f). In line with this finding, a strong cell-cycle
effect was not observed 24–48 h after irradiation compared
with a clear accumulation of cells at the G1/S boundary
upon hydroxyurea treatment (Supplementary Figure S2),
suggesting that the pRb changes may be important for the
maintenance of cell cycle progression during the immediate
IR response.
IR
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0.25 h
U
0.5 2 4 8 0.5 2 4 8 0.5 2 4 8
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DNA-PKi
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Figure 1 Induction of the DRR and efficient repair of IR-induced DNA breaks over 48 h in NHFs. (a) Western blot analysis of irradiated MRC-5 cells after recovery from IR
for 0.5–8 h. (b) Immunofluorescence staining of MRC-5 cells irradiated with X-ray doses of 1–10 Gy or left untreated (U) and recovered for 15 min–8 h. (c) MRC-5 cells were
pretreated with 10mM KU-55933 (ATMi) and/or 10 mM Nu7441 (DNA-PKi) before irradiation with 6 Gy, or left untreated (U) as a control. Cells were stained with anti-gH2A.X
(phospho-Ser139) 1 h post-irradiation. ATM, Ataxia-telangiectasia mutated; Chk, checkpoint kinase; DAPI, 40,6-diamidino-2-phenylindole; DNA-PK, DNA protein kinase;
DMSO, dimethyl sulfoxide
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The role of the p53 pathway in DDR and its function as a
‘guardian of the genome’23,24 is emphasized by the fact that it
was significantly over-represented among the proteins
responding to both 10 and 40Gy IR (Figure 3a), and by its
many interactions (more than 14 interactions) in the predicted
protein network (Figure 3b and Supplementary Figure S10g).
The agreement of the RPPA analysis with western blot
quantifications, as well as the identification of the known key
players in the DDR, confirmed the validity of the RPPA
approach described here and proved that the IR-treated cells
used in these experiments launched a classical DDR.
IR upregulates antiapoptotic and prosurvival markers in
MRC-5 cells. The kinetic RPPA analysis described here
also revealed many new cytoplasmic factors, which were
further analyzed in more detail. The here identified changes
included prosurvival signals CREB (pS133) as well as MEK1/
2 (pS217/222, pS221/226), ERK1/2 (pT202/185, pY204/187)
and AMPK (pT172) for 40Gy only, antiapoptotic markers
(Bad pS112 and pS136, Bcl-2 pS70 for 10Gy only) as well as
a cluster comprising protein kinase C (PKC) family members.
The changes in PKC family members included the phos-
phorylation of the novel PKC-d (pT505) and of the atypical
PKCz/l (pT410/403) in the activation loop (Figures 2b and c),
which marks the activated state of these two PKC isoforms.25
These analyses suggested that IR treatment of primary
fibroblasts activates not only the classical DDR pathways
MEK-ERK and p38-Hsp27 but that also the cytoplasmic PKC
signaling and specific antiapoptotic and prosurvival factors
were regulated. It is thus possible that PKC signaling is
involved in mediating the high IR resistance of MRC-5 and
IMR-90 cells by preventing apoptosis and stimulating
prosurvival factors.
Inhibitor screen identifies PKC signaling as important
for IR resistance. To elucidate whether PKC or other main
signaling cascades regulate cell viability in NHFs upon IR
treatment, a radiosensitivity screen with inhibitors specific for
key components of the MEK-ERK, p38, JNK or PKC
pathways was performed (Figure 4 and Supplementary
Figures S11a–e). While JNK inhibitors had only a weak
effect on cell viability, inhibition of MEK and p38 affected cell
proliferation, but independent of IR (i.e., similar effect in
treated and untreated cells). Interestingly, already 48 h after
the cotreatment with either one of two PKC inhibitors
(GF109203X or Ro-318220) and with IR, MRC-5 cells
showed a significant reduction in cell viability compared with
cells treated with DMSO (the solvent) or with IR alone
(Figure 4 and Supplementary Figure S11). The NHF strain
IMR-90 behaved similarly and showed a significant reduction
-0.8
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Figure 2 Identification of significant proteome changes in response to IR. (a) Workflow for the characterization of IR-induced proteome changes by RPPA. MRC-5 cells
were left untreated (U) or irradiated in biological triplicates with 10 or 40 Gy. At different time points, cell lysates were prepared and spotted in equal amounts on hydrophobic
glass slides. Each array was incubated with a different primary antibody, directed against a protein of interest and a secondary fluorophore-labeled antibody. Relative
fluorescence intensities were quantified and used for statistical data analysis to identify significant proteome changes in response to irradiation. (b and c) Time-profile
clustering of IR-dependent proteome changes (analysis of variance (ANOVA), Po0.05; 1.5 S.D. cutoff) using Self-Organizing Tree Algorithm (SOTA) showing protein
expression and modification (e.g., phosphorylation) in green or downregulation and de-modification (e.g., de-phosphorylation) in red. (b) Clustering of proteome changes upon
irradiation with 10 Gy. (c) Clustering analysis of IR-dependent proteome changes upon 40 Gy treatment. AMPK, AMP-activated protein kinase; Bad, Bcl2 antagonist of cell
death; EGFR, epidermal growth factor receptor; elF4E, Eukaryotic initiation factor elF4E like protein; ERK, extracellular signal-regulated kinase; Hsp, heat-shock protein; JNK,
c-Jun NH2-terminal kinase; MAPK, mitogen-activated protein kinase; MEK, MAPK/ERK kinase; PAK, p21-activated kinase; PKA RII, cAMP-dependent protein kinase type II
regulatory subunit; PKC, protein kinase C; Rb, Retinoblastoma-associated protein; SAPK, stress-activated protein kinase; SMAD, Homolog of mothers against
decapentaplegic homolog from Drosophila and SMA from Caenorhabditis elegans; Stat6, signal transducer and activator of transcription 6
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Figure 3 Pathway and protein–protein interaction analysis of significant IR-induced proteome changes. (a) Enrichment of pathways from the pathway interaction database
(PID) with significant proteome changes (analysis of variance (ANOVA), Po0.05; 1.5 S.D.) induced by 10 Gy only (red), 40 Gy only (blue) and overlapping changes (green)
using Fisher’s exact test. (FDR-corrected P-value cutoff¼ 0.1). (b) Protein–protein interaction analysis of significant proteome changes induced by 40 Gy using STRING, with
a STRING score cutoff40.7. Colors indicate phosphorylation (light blue), total protein changes (violet), phosphorylation and total protein changes (orange). Circles represent
unique changes and squares overlapping changes. Large symbols indicate proteins that interact with more than 14 members. BAD, Bcl2 antagonist of cell death; CCND,
Cyclin D; CDC42, Cell division control protein 42 homolog; CDKN1A, Cyclin-dependent kinase inhibitor 1A (p21); CHEK1, Checkpoint kinase-1; CXCR3, C-X-C chemokine
receptor type 3; EGFR, Epidermal growth factor receptor; EPHB, Ephrin type-B receptor; ErbB, Epidermal growth factor receptor; HSPB, Heat shock protein beta; MAP2K1,
Dual specificity mitogen-activated protein kinase kinase 1 (MEK1); MAP2K2, Dual specificity mitogen-activated protein kinase kinase 2 (MEK2); MAP2K3, Dual specificity
mitogen-activated protein kinase kinase 3 (MKK3); MAP2K6, Dual specificity mitogen-activated protein kinase kinase 6 (MKK6); MAPK, mitogen-activated protein kinase;
MAPK1, Mitogen-activated protein kinase 1 (ERK-2); MAPK3, Mitogen-activated protein kinase 3 (ERK-1); MAPKAP2, MAP kinase-activated protein kinase 2 (MK2); PAK,
p21-activated kinase; PRKAA1, 5’-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK1); PRKCD, protien kinase C delta type; PRKCZ, Protein kinase C zeta type;
PRL, prolactin; SRC, Proto-oncogene tyrosine-protein kinase Src; STK11, Serine/threonine-protein kinase STK11 (LKB1); Trk, tropomyosin-receptor-kinase.
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in growth when treated with the PKC inhibitor GF109203X
(2.5 mM) and either 10 or 40Gy irradiation (Supplementary
Figures S12a–c). These results implicated PKC activity and
signaling in the radiosensitivity of MRC-5 and IMR-90 cells.
Inhibition or downregulation of PKC directs cells
towards apoptosis. To confirm and validate PKC activation
upon IR, western blot analyses were performed. In agree-
ment with the RPPA results and the inhibitor studies,
phosphorylation of PKCz/l (pT410/pT403) as well as of
PKCb (pT641) were confirmed to be increased upon IR
(Figures 5a and b). To further characterize the mechanism of
the PKC-dependent reduction in cell viability, one prosurvival
(CREB phosphorylation)26 and one antiapoptotic marker
(phosphorylation of Bad)27 was analyzed in more detail by
western blotting (Figures 5c–e). In combination with IR
treatment, PKC inhibition or downregulation caused strongly
reduced phosphorylation of CREB (pS133) and Bad (pS136),
while the total protein levels were only marginally affected
(Figures 5c and d for MRC-5; Figure 5e for IMR-90). Intere-
stingly, ATM (pS1981) was not affected by PKC inhibition
(Figures 5c and e) and did not affect CREB phosphorylation
or protein levels (Figure 5c), suggesting that the PKC
pathway is activated independent of the classical DDR.
Although primary human fibroblasts are known to undergo
senescence as a response to irradiation, the reduced
phosphorylation of CREB and Bad, as well as the reduced
cell viability, upon IR treatment and PKC inhibition or
downregulation indicated the induction of apoptosis.28,29 It
was therefore assessed whether irradiation and PKC inhibi-
tion affects senescence and possibly induces apoptosis.
Upon PKC inhibition and irradiation with 10 or 40Gy, MRC-5
and IMR-90 cells both showed reduced b-galactosidase
staining as compared with the DMSO-treated control, which
is indicative of reduced senescence (Figure 5f and Supple-
mentary Figure S13a). Using an alternative senescence
marker, reduced p16 protein levels upon irradiation, in
combination with PKC inhibition or downregulation, could be
confirmed in MRC-5 cells (Figure 5h). The p16 levels were not
significantly reduced in IMR-90 cells in response to IR and
PKC inhibition; however; the significant reduction in p21
protein levels (Supplementary Figures S13b and c) was
another alternative indicator for cellular senescence.30 In
contrast, in the presence of PKC inhibitors, IR treatment led to
induced levels of the proapoptotic marker Bad and reduced
amounts of the antiapoptotic marker Bcl-2, persistently
increased p53 protein levels (in addition to the temporary
p53 stabilization observed as a response to IR alone) and
ARTD1 (PARP-1) cleavage (reduction in ARTD1 full-length
levels and accumulation of the 89 kDa cleavage fragment), all
suggestive of a switch from senescence to apoptosis, specifi-
cally upon IR in combination with PKC inhibitor treatment or
PKC knockdown after 48 h of IR recovery (Figures 5g and h).
Reduced ARTD1 levels and an increased sub-G1 cell
population in the NHF strain IMR-90 also confirmed the
findingswith theMRC-5 strain (Supplementary Figures S13b–
f), in addition to the reduced senescence and cell viability
upon IR treatment in combination with PKC inhibition.
In summary, these results demonstrated the IR-dependent
activation of cytoplasmic PKC signaling and discovered the
consecutive PKC-dependent activation of prosurvival signal-
ing mediated via CREB and Bcl-2 as well as the inactivation of
proapoptotic pathways (Bad), which direct normal human
MRC-5 and IMR-90 fibroblasts towards senescence and
prevent IR-induced apoptosis (Figure 6). Activation of
cytoplasmic PKC signaling upon IR is thus a novel mechanism
that orchestrates the different IR-induced responses to
ensure cell survival of primary human fibroblasts.
Discussion
Human primary fibroblasts such as MRC-5 cells are able to
repair DNA damage induced by IR doses up to 80Gy.16,17
However, it was so far not clear howMRC-5 fibroblasts prevent
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apoptosis, which is induced at much lower IR doses in other
cell types.31 Understanding the dynamics of in vivo signaling
events in response to IR in human primary fibroblast may thus
reveal medically relevant IR resistance mechanisms.
The network analysis of IR-induced proteome changes in
MRC-5 fibroblasts presented here identified upregulation of
known DDR factors (H2AX, p53, p21, MKK3/6, p38, MK2,
Hsp27, Chk2) only 2–8 h after irradiation (Supplementary
Table). In contrast, growth factor- and cytokine-dependent
signaling pathways including members of the MAPK family
(MEK/ERK), PKC family (PKCd, PKCz/l, PKCbII) as well as
anti- and proapoptotic Bcl-2 family members (Bcl-2, Bad)
tended to respond with faster kinetics and thus indicated that
cytoplasmic signaling events are upstream of the canonical
DDR. Indeed, an increasing body of evidence implicates an
IR-dependent cytoplasmic signaling network in regulating
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DNA break repair.32 Although RPPA analysis is restricted by
antibody performance and reduced dynamic range, western
blotting confirmed the tested proteome changes discovered
by RPPA analysis, supporting the stringent statistical analy-
sis. However, western blotting indicated that RPPA analysis
usually underestimated the IR-induced proteome changes.
Most proteome changes, in particular upon 40Gy IR,
affected mitogenic signaling events controlling cell survival
(MKK3/6-p38-MK2 pathway, MEK-ERK pathway, LKB-AMPK
pathway, PKC-Bad pathway). Previously published results
have demonstrated p38-MK2 pathway activation and sub-
sequent cell cycle arrest in G2/M in response to UV irradiation,
thus protecting DNA damaged cell from entering mitosis,
which would lead to a mitotic catastrophe and eventually to
apoptosis.33,34 In agreement with these findings, in response
to 10 and even more pronounced upon 40Gy, we could show
activation of the major p38-MK2 pathway components, with
phosphorylation of MKK3/6, p38, MAPKAP-2 (MK2) and
Hsp27, besides the slight increase in the percentage of the
G2/M cell cycle population 24–48 h after IR recovery
(Supplementary Figures S2 and S7).
The most important finding of this systematic RPPA
analysis is the identification of PKC as a key player that
orchestrates the downstream signaling pathways regulating
apoptosis and cell survival (Figure 6). IR-dependent PKC
activation regulated Bad, Bcl-2 and CREB to prevent
apoptosis and to induce prosurvival signaling. Whether
PKC family members directly phosphorylate the identified
downstream proteins or rather indirectly affect their activa-
tion is currently not known. Interestingly, PKCs are known to
translocate to the nucleus35 and all identified regulatory
components (Bad, Bcl-2, CREB) contain putative target sites
for phosphorylation by PKC.36 PKC inhibitors, or PKC
downregulation before IR treatment, downregulated antia-
poptotic factors (Bad phosphorylation, Bcl-2) and induced
apoptosis (ARTD1 cleavage, increased p53 stabilization,
Bad upregulation, increased sub-G1 population and decline
in cell number). Sensitization of primary fibroblasts by PKC
inhibitors or downregulation thus induced an apoptotic
program that is mediated by effects on CREB, Bad and
proapoptotic genes. PKC-dependent regulation of cell
survival, apoptosis as well as cell cycle progression is thus
proposed as a part of the mechanism by which primary
fibroblasts resist high IR doses and circumvent apoptosis,
which is in agreement with the high DNA repair efficiency and
the PKC-dependent regulation of p53 function.16,37 The
inhibitor and siRNA experiments described here imply PKC
signaling in the prevention of apoptosis in human primary
MRC-5 and IMR-90 fibroblasts. However, these analyses do
not identify which PKC family member mediates the
observed phenotypes. The RPPA analysis identified PKCd
activation, which was previously shown to be induced upon
DNA damage38 and linked to pro- and antiapoptotic functions
(Basu and Pal39 and many reference therein). Future studies
on the upstream regulators relevant for PKC activation upon
IR in MRC-5 and IMR-90 cells will identify the required
cofactors and signaling components and thereby indicate
which PKC subgroup mediates the antiapoptotic function.
Taken together, our findings provide the cellular mechanism,
which is responsible for this phenotype andmay thus open up
possiblities for new treatment schemes of highly IR-resistant
tumors.
This result has not only important implications for our
understanding of the IR response but also for the comprehen-
sion of nuclear regulatory events and supports the concept of
the cellular, in contrast to the nuclear, radiation response.40
Cellular stress such as IR is perceived at the plasma
membrane and in the cytoplasm and initiates cytoplasmic
signaling pathways that consecutively control nuclear events
such as DNA repair. This is also suggested by the induction of
IR-induced signaling in cells exposed to IR conditioned
medium, which is termed the ‘bystander effect’.41 The
classical DDR, comprised of nuclear events regulating cell
cycle progression and DNA repair, is thus preceded and
controlled by the cytoplasmic radiation response, which is
mediated by the PKC signaling pathway as well as other
signaling pathways such as the MEK-ERK pathway.
This RPPA network analysis of IR-induced signaling
identified a new, cytoplasmic, PKC-dependent regulatory
mechanism that conditions stressed cells by preventing
apoptosis. The PKC-dependent induction of prosurvival
signaling and evasion of apoptosis is thus a mechanism,
which renders primary human fibroblasts resistant to high
doses of IR, and may thereby protect the microenvironment
and permit survival of tumors. Our results thus provide an
explanation for the cellular response to severe irradiation
stress and will therefore help optimize and improve
radiotherapy.
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Figure 6 Model of PKC-dependent cellular prosurvival signaling in response to
IR. IR-induced PKC signaling orchestrates cell survival via upregulation of Bcl-2 and
phosphorylation of Bad and CREB. Hypersensitization with PKC inhibitors
(GF109203X, Ro-318220) and genetic knock down (siPKC pan) leads to IR-
induced activation of apoptosis mediated by p53 stabilization, upregulation of Bad
and ARTD1 cleavage, as well as reduced senescence mediated via decrease in p21
protein levels and reduced b-galactosidase (b-Gal) activity in response to IR.
ARTD1, ADP-ribosyltransferase diphtheria toxin-like 1; Bad, Bcl2 antagonist of cell
death; Bcl-2, B-cell lymphoma 2; CREB, cAMP response element-binding protein
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Materials and Methods
Cell culture, IR treatment, siRNA transfection, lysis, viability
and senescence assays. The MRC-5 and IMR-90 human lung fibroblast
cell strains42,43 were obtained from the American Type Culture Collection and
cultured in supplemented MEM (Invitrogen; Life Technologies, Carlsbad, CA, USA).
Cells were exposed to IR using an X-ray generator (Pantak Seifert X-ray System,
Ahrensburg, Germany; 120 kV; 19 mA; aluminum filter, 3.11 Gy/min) and recovered
for different time periods. Inhibitor treatment was performed as indicated in the figure
legends before the exposure to IR. To reduce PKC expression, 1 105 MRC-5 cells
were transfected using human siPKC pan (Santa Cruz Biotechnology, Dallas, TX,
USA; sc-29449) over 3 and 4 days, before irradiation. Whole cell extracts were
prepared with Zeptosens Cell Lysis Buffer CLB1 (Bayer Technology Services
GmbH, Leverkusen, Germany) or RIPA lysis buffer and total protein concentration
was determined using the standard Lowry method. Cell viability was determined by
seeding 2 103 cells in 96-well plates overnight before irradiation or drug treatment.
Cell viability was quantified using the WST-1 proliferation reagent (Roche, Basel,
Switzerland) or alamarBlue cell viability assay (Invitrogen) and a plate reader
(Tecan, Ma¨nnedorf, Switzerland). The clonogenic and senescence assays were
performed as described elsewhere.44,45
Reverse phase protein arrays. RPPA were prepared as described.46 In
brief, whole cell extracts were spotted onto hydrophobically coated Zeptosens Chips
(Bayer Technology Services GmbH). Serially diluted lysates (100, 75, 50 and 25%)
were arrayed in duplicates onto hydrophobic Zeptosens Chips using the Nanoplotter
NP2.0 (GeSiM; Gesellschaft fu¨r Silizium-Mikrosysteme mbH, Grosserkmannsdorf,
Germany), followed by blocking in an ultrasonic nebulizer (ZeptoFOG; Bayer
Technology Services GmbH). Antibody incubation, microarray data acquisition
(ZeptoREADER; Bayer Technology Services GmbH) and data analysis (ZeptoVIEW
version 3.1.0.2; Bayer Technology Services GmbH) was performed exactly as
described.47 The eight data points (100, 75, 50 and 25% lysate amount in duplicates)
were fitted using a weighted linear least-squares fit48 and the relative fluorescence
intensity determined by interpolating at the median protein concentration or
modification. To correct for small variations in protein content, relative intensities
were normalized to the signals of b-catenin, which did not show any significant
variation (ANOVA, Po0.05; 1.5S.D.) in response to IR over indicated time points.
Significance and clustering analysis. To identify significant proteome
changes in response to IR, relative fluorescence intensities were imported to MeV
version 4.6.49 Relative fluorescence intensities were log 2 transformed and
normalized, before performing statistical analysis using one-way ANOVA as
described in Zar.50 The mean transformed fluorescence intensities for group 1
(untreated: 0.5, 2, 4 and 8 h), group 2 (biological triplicates of 10 or 40 Gy at 0.5 h),
group 3 (biological triplicates of 10 or 40 Gy at 2 h), group 4 (biological triplicates of
10 or 40 Gy at 4 h) and group 5 (biological triplicates of 10 or 40 Gy at 8 h) were
compared using F-statistics with Po0.05. Owing to technical problems during
preparation of the serial dilution of the whole cell extracts, two biological replicates
for the 8 h time point of 10 Gy irradiated samples (10 Gy at 8 h) and one biological
replicate for the 2 and 8 h time point of 40 Gy irradiated samples (40 Gy at 2 h and
40 Gy at 8 h) were excluded from the statistical analysis. For fold-change analysis,
transformed means of the biological replicates were normalized to the untreated
sample (set as 1) and proteome changes were filtered (cutoff set at 1.5S.D.
equal to log 240.27/o 0.27 for 10 Gy or log 240.29/o 0.29 for 40 Gy).
Significant proteome changes in response to IR were selected, if significant by
one-way ANOVA (Po0.05) and fold cutoff (1.5 S.D.). Alternatively, significance
analysis was performed using two-tailed Student’s t-test (Po0.05). Similar profiles
of the fold changes over time were identified by clustering analysis using the Self
Organizing Tree Algorithm51 and default parameters of MeV version 4.6.49
Pathway and network analysis. Gene pathway membership data were
obtained from protein interaction database, PID52 and KEGG.53 A total of 200 and
211 pathways were obtained from PID and KEGG, respectively. For statistical
analysis, all analyzed proteins in this study (unique IDs) were set as the
background list and all pathways consisting of more than five proteins from the
background list were considered for statistical analysis by Fisher’s exact test,
resulting in a total of 93 pathways from PID and 63 from KEGG. Fisher’s exact test
was performed to identify pathways significantly affected by proteins (modifica-
tions) altered in response to irradiation (significant by ANOVA and fold change)
using the R statistical framework.54 To account for multiple testing, P-values were
corrected for false discovery rates (FDRs) using Benjamini–Hochberg correction.
We have used an FDR-corrected P-value cutoff of 0.1 to identify pathways
significantly affected by proteome changes.
Significant proteome changes, identified by statistical (ANOVA) and fold-change
analysis (log 2 cutoff) were subjected to protein–protein interaction analysis using
STRING (v. 9.0, http://www.string-db.org/).55 Only interactions with a STRING score of
0.7 and above were further analyzed using Cytoscape (http://www.cytoscape.org/).56
Immunoblotting. For western blot analysis, proteins were separated by SDS-
PAGE gel electrophoresis and bands were visualized by using either horseradish
peroxidase-conjugated antibodies (1 : 5000; GE Healthcare, Life Sciences,
Uppsala, Sweden) and ECL detection (GE Healthcare) or IR-dye-conjugated
antibodies (1 : 15 000; LI-COR Biosciences) and detection by the Odyssey infrared
imaging system (LI-COR Biosciences, Lincoln, NE, USA). For quantification,
bands were analyzed by ImageJ 1.46 (ref. 57) and the Odyssey imaging software
(LI-COR Biosciences).
Antibodies used for western blotting were anti-ATM (GeneTex, Irvine, CA, USA),
anti-ATM Phospho (pS1981) (Epitomics-an Abcam Company, Burlingame, CA,
USA), anti-Bad (CST), anti-Bad Phospho (pS136) (Cell Signaling Technology
(CST), Danvers, MA, USA), anti-Chk1 (CST), anti-Chk1 Phospho (pS345) (1 : 500;
CST), anti-Chk2 Phospho (pT68) (CST), anti-CREB (CST), anti-CREB Phospho
(pS133)/anti-ATF-1 (phospho) (CST), anti-histone H2A.X Phospho (pS139)
(Millipore, Billerica, MA, USA), anti-Hsp27 (CST), anti-Hsp27 Phospho (pS78)
(1 : 500; CST), anti-PARP1 (Santa Cruz Biotechnology), anti-PARP1 cleaved
(1 : 500; CST), anti-p16 (1 : 500; Santa Cruz Biotechnology), anti-p21 (Santa Cruz
Biotechnology), anti-p38 (CST), anti-p38 Phospho (pThr180/Tyr182), anti-p44/42
Erk1/2 (CST), anti-p44/42 Erk1/2 Phospho (pThr202/Tyr204) (CST), anti-p53
(Santa Cruz Biotechnology), anti-Rb (1 : 500; Epitomics), anti-Rb (pS780) (CST),
anti-tubulin (1 : 10 000; Sigma-Aldrich, St Louis, MO, USA), anti-PKCbII Phospho
(pT641) (CST), anti-PKCd (CST), anti-PKCz/l (CST) and anti-PKCz/l Phospho
(pT410/pT403) (CST). Unless otherwise stated, antibody dilution was 1 : 1000.
Immunofluorescence microscopy. MRC-5 cells grown on cover slips
over night (E1 104 cells) were irradiated and immunohistochemically stained
with primary (1 : 500 mouse anti-histone H2A.X Phospho (S139) immunoglobulin
G1 (IgG1) (Millipore) or 1 : 500 rabbit anti-53BP1 IgG1 (Santa Cruz Biotechnol-
ogy)) and secondary antibodies (1 : 250 FITC- or cyanine 3-conjugated IgG anti-
mouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) or
1 : 250 Alexa Fluor 488-conjugated anti-rabbit IgG (Invitrogen)).
Flow cytometry. Cell cycle analysis of IR-treated or -untreated MRC-5 cells
was performed using standard ethanol fixation/PI-staining protocol and flow
cytometry analysis (FACS) with a Dako CyAn ADP flow cytometer (Dako, North
America, Carpinteria, CA, USA). For sub-G1 peak analysis of IMR-90, cell debris
and necrotic cells were gated out according to the protocol of Riccardi and
Nicoletti.58 Annexin V staining was performed using the FITC Annexin V apoptosis
detection kit (BD Biosciences, San Jose, CA, USA) and a Dako CyAn ADP flow
cytometer (Dako).
RNA extraction and real-time PCR analysis. Total RNA was reverse
transcribed using High-Capacity cDNA Reverse Transcription kit (Applied
Biosystems; Life Technologies). Real-time PCR was performed using SYBR
green premixed buffer and analyzed by the Rotor-Gene Q cycler (Qiagen, Hilden,
Germany).
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